212 related articles for article (PubMed ID: 19466425)
1. Anti-inflammatory mechanism of tocilizumab, a humanized anti-IL-6R antibody: effect on the expression of chemokine and adhesion molecule.
Suzuki M; Hashizume M; Yoshida H; Mihara M
Rheumatol Int; 2010 Jan; 30(3):309-15. PubMed ID: 19466425
[TBL] [Abstract][Full Text] [Related]
2. IL-6/sIL-6R trans-signalling, but not TNF-alpha induced angiogenesis in a HUVEC and synovial cell co-culture system.
Hashizume M; Hayakawa N; Suzuki M; Mihara M
Rheumatol Int; 2009 Oct; 29(12):1449-54. PubMed ID: 19277666
[TBL] [Abstract][Full Text] [Related]
3. Soluble interleukin-6 receptor alpha inhibits the cytokine-Induced fractalkine/CX3CL1 expression in human vascular endothelial cells in culture.
Matsumiya T; Imaizumi T; Fujimoto K; Cui X; Shibata T; Tamo W; Kumagai M; Tanji K; Yoshida H; Kimura H; Satoh K
Exp Cell Res; 2001 Sep; 269(1):35-41. PubMed ID: 11525637
[TBL] [Abstract][Full Text] [Related]
4. IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17.
Hashizume M; Hayakawa N; Mihara M
Rheumatology (Oxford); 2008 Nov; 47(11):1635-40. PubMed ID: 18786965
[TBL] [Abstract][Full Text] [Related]
5. Enhanced angiogenic function in response to fibroblasts from psoriatic arthritis synovium compared to rheumatoid arthritis.
Fromm S; Cunningham CC; Dunne MR; Veale DJ; Fearon U; Wade SM
Arthritis Res Ther; 2019 Dec; 21(1):297. PubMed ID: 31864394
[TBL] [Abstract][Full Text] [Related]
6. Influence of humanized anti-IL-6R antibody, tocilizumab on the activity of soluble gp130, natural inhibitor of IL-6 signaling.
Hashizume M; Mihara M
Rheumatol Int; 2009 Feb; 29(4):397-401. PubMed ID: 18802703
[TBL] [Abstract][Full Text] [Related]
7. Fibroblasts from different sites may promote or inhibit recruitment of flowing lymphocytes by endothelial cells.
McGettrick HM; Smith E; Filer A; Kissane S; Salmon M; Buckley CD; Rainger GE; Nash GB
Eur J Immunol; 2009 Jan; 39(1):113-25. PubMed ID: 19130557
[TBL] [Abstract][Full Text] [Related]
8. Dehydroepiandrosterone inhibits the TNF-alpha-induced inflammatory response in human umbilical vein endothelial cells.
Gutiérrez G; Mendoza C; Zapata E; Montiel A; Reyes E; Montaño LF; López-Marure R
Atherosclerosis; 2007 Jan; 190(1):90-9. PubMed ID: 16574124
[TBL] [Abstract][Full Text] [Related]
9. Statins suppress interleukin-6-induced monocyte chemo-attractant protein-1 by inhibiting Janus kinase/signal transducers and activators of transcription pathways in human vascular endothelial cells.
Jougasaki M; Ichiki T; Takenoshita Y; Setoguchi M
Br J Pharmacol; 2010 Mar; 159(6):1294-303. PubMed ID: 20136831
[TBL] [Abstract][Full Text] [Related]
10. Fibrin(ogen)-induced expression of ICAM-1 and chemokines in human synovial fibroblasts.
Liu X; Piela-Smith TH
J Immunol; 2000 Nov; 165(9):5255-61. PubMed ID: 11046059
[TBL] [Abstract][Full Text] [Related]
11. IL-6 regulates MCP-1, ICAM-1 and IL-6 expression in human myoblasts.
Marino M; Scuderi F; Provenzano C; Scheller J; Rose-John S; Bartoccioni E
J Neuroimmunol; 2008 May; 196(1-2):41-8. PubMed ID: 18400310
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 (IL-6) induces the proliferation of synovial fibroblastic cells in the presence of soluble IL-6 receptor.
Mihara M; Moriya Y; Kishimoto T; Ohsugi Y
Br J Rheumatol; 1995 Apr; 34(4):321-5. PubMed ID: 7788145
[TBL] [Abstract][Full Text] [Related]
13. IL-6 amplifies TLR mediated cytokine and chemokine production: implications for the pathogenesis of rheumatic inflammatory diseases.
Caiello I; Minnone G; Holzinger D; Vogl T; Prencipe G; Manzo A; De Benedetti F; Strippoli R
PLoS One; 2014; 9(10):e107886. PubMed ID: 25271853
[TBL] [Abstract][Full Text] [Related]
14. Production of chemokines, interleukin-8 and monocyte chemoattractant protein-1, during monocyte: endothelial cell interactions.
Lukacs NW; Strieter RM; Elner V; Evanoff HL; Burdick MD; Kunkel SL
Blood; 1995 Oct; 86(7):2767-73. PubMed ID: 7545470
[TBL] [Abstract][Full Text] [Related]
15. IL-6 inhibits the proliferation of fibroblastic synovial cells from rheumatoid arthritis patients in the presence of soluble IL-6 receptor.
Nishimoto N; Ito A; Ono M; Tagoh H; Matsumoto T; Tomita T; Ochi T; Yoshizaki K
Int Immunol; 2000 Feb; 12(2):187-93. PubMed ID: 10653854
[TBL] [Abstract][Full Text] [Related]
16. Effects of protein tyrosine kinase inhibitors on cytokine-induced adhesion molecule expression by human umbilical vein endothelial cells.
May MJ; Wheeler-Jones CP; Pearson JD
Br J Pharmacol; 1996 Aug; 118(7):1761-71. PubMed ID: 8842442
[TBL] [Abstract][Full Text] [Related]
17. Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family.
Mihara M; Kasutani K; Okazaki M; Nakamura A; Kawai S; Sugimoto M; Matsumoto Y; Ohsugi Y
Int Immunopharmacol; 2005 Nov; 5(12):1731-40. PubMed ID: 16102523
[TBL] [Abstract][Full Text] [Related]
18. Role of IL-6 and the soluble IL-6 receptor in inhibition of VCAM-1 gene expression.
Oh JW; Van Wagoner NJ; Rose-John S; Benveniste EN
J Immunol; 1998 Nov; 161(9):4992-9. PubMed ID: 9794436
[TBL] [Abstract][Full Text] [Related]
19. Role of the IL-6 classic- and trans-signaling pathways in corneal sterile inflammation and wound healing.
Ebihara N; Matsuda A; Nakamura S; Matsuda H; Murakami A
Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8549-57. PubMed ID: 21989726
[TBL] [Abstract][Full Text] [Related]
20. CD154 (CD40L) induces human endothelial cell chemokine production and migration of leukocyte subsets.
Thienel U; Loike J; Yellin MJ
Cell Immunol; 1999 Dec; 198(2):87-95. PubMed ID: 10648122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
